USVP | Jotup

Cagent Vascular Raises $30 Million Series C Financing

Retrieved on:

Tuesday, February 20, 2024

Health, FDA, Medical Devices, Hospitals, Surgery, General Health, Cardiology, U.S. Venture Partners, General partnership, Physician, PAD, Silicon, USVP, Patient, Pharmaceutical industry

Cagent Vascular, Inc., a rapidly growing commercial stage medical device company, today announced a Series C Financing close in excess of $30M.

Key Points:

Cagent Vascular, Inc., a rapidly growing commercial stage medical device company, today announced a Series C Financing close in excess of $30M.
Participation included new investor Blue Ridge Medical, LLC and existing investors, including Sectoral Asset Management.
“We are pleased with the significant investment from U.S. Venture Partners and other new and existing investors.
This was further underscored by the strong early commercial success driven by the exceptional team at Cagent Vascular,” said Casey Tansey, General Partner, US Venture Partners.

IONIX Completes $42M Financing Round to Expand Threat Exposure Management Across the Entire Attack Surface

Retrieved on:

Tuesday, February 6, 2024

Professional Services, Security, Technology, Other Technology, Software, Venture Capital, Networks, Multimedia, USVP, Palo Alto Networks, Mean Time, IPO, Corporation, ASM, U.S. Venture Partners, Business, MTTR, Software as a service, Risk management

View the full release here: https://www.businesswire.com/news/home/20240206769819/en/

Key Points:

View the full release here: https://www.businesswire.com/news/home/20240206769819/en/
IONIX Completes $42M Financing Round to Expand Threat Exposure Management Across the Entire Attack Surface (Photo: Business Wire)
IONIX will use the funds to accelerate go-to-market activities, development of its product roadmap and to expand the Threat Exposure Management capabilities of its industry-leading Attack Surface Management solution.
“Our mission is to give them the widest possible view of their attack surface looking from the outside in, like an attacker would.
Customers of IONIX discover up to 50% more assets and greatly reduce MTTR (Mean Time to Resolution) of threats.
“The Attack Surface Management market holds immense potential, and I see IONIX as an innovator within it.

Achieving Five-Fold Revenue Growth, Zero Networks Raises $20M in Series B to Prevent Attackers from Spreading in Corporate Networks

Retrieved on:

Wednesday, December 13, 2023

U.S. Venture Partners, CrowdStrike, Organization, USVP, General partnership, Marketing, Venrock, Software as a service, Growth, Hospital, TEL, Cryptocurrency, Arms industry

ORLANDO, Fla. and TEL AVIV, Israel, Dec. 13, 2023 /PRNewswire/ -- Israeli cybersecurity startup Zero Networks, a leading provider of zero trust identity and network security solutions, raised $20 million in Series B funding following a five-fold increase in its revenue, bringing its total raised capital to $45 million.

Key Points:

The funds will be utilized to recruit development, marketing, and sales personnel, supporting Zero Networks' hypergrowth.
Zero Networks was founded in 2019, and is led by Benny Lakunishok, the CEO, and Amir Frankel, the CTO.
In addition, Zero Networks enables organizations to securely connect remote employees and third parties to their network with zero trust principles and maximum network performance.
Now, I'm excited to help Zero Networks revolutionize the other huge market that is ripe for disruption - Network Security."

Achieving Five-Fold Revenue Growth, Zero Networks Raises $20M in Series B to Prevent Attackers from Spreading in Corporate Networks

Retrieved on:

Wednesday, December 13, 2023

U.S. Venture Partners, CrowdStrike, Organization, Multimedia, USVP, General partnership, Marketing, Venrock, Software as a service, Growth, Hospital, TEL, Cryptocurrency, Arms industry, Online shopping

ORLANDO, Fla. and TEL AVIV, Israel, Dec. 13, 2023 /PRNewswire/ -- Israeli cybersecurity startup Zero Networks, a leading provider of zero trust identity and network security solutions, raised $20 million in Series B funding following a five-fold increase in its revenue, bringing its total raised capital to $45 million.

Key Points:

The funds will be utilized to recruit development, marketing, and sales personnel, supporting Zero Networks' hypergrowth.
Zero Networks was founded in 2019, and is led by Benny Lakunishok, the CEO, and Amir Frankel, the CTO.
In addition, Zero Networks enables organizations to securely connect remote employees and third parties to their network with zero trust principles and maximum network performance.
Now, I'm excited to help Zero Networks revolutionize the other huge market that is ripe for disruption - Network Security."

Darwinium Raises $18 Million to Accelerate Global Adoption of its Edge-based Digital Security and Fraud Prevention Platform

Retrieved on:

Wednesday, October 18, 2023

Darwinium , a next-generation digital security and fraud prevention platform, today announced it has raised $18 million in Series A financing led by U.S. Venture Partners (USVP), with participation from seed investors: Blackbird, Airtree Ventures and Accomplice.

Key Points:

Darwinium , a next-generation digital security and fraud prevention platform, today announced it has raised $18 million in Series A financing led by U.S. Venture Partners (USVP), with participation from seed investors: Blackbird, Airtree Ventures and Accomplice.
View the full release here: https://www.businesswire.com/news/home/20231018042938/en/
Darwinium raises $18 million to accelerate global adoption of its edge-based digital security and fraud prevention platform.
(Photo: Business Wire)
Online fraud has become more complex and harder to detect, facilitated by AI-tooling that is being exploited by adversaries.
“Darwinium offers a product that is both simple to deploy and effective at reducing fraud losses and reputational damage associated with the ever-more complex web of digital fraud.

Neuros Medical, Inc. Names David Veino as President and CEO and Expands Board of Directors

Retrieved on:

Monday, October 23, 2023

Ban, Abbott, FDA, NYSE, Stryker, Physician, General partnership, PMA, Inspiration, Amputation, Quality of life, U.S. Venture Partners, USVP, Patient, Obstructive sleep apnea, Management, Pharmaceutical industry, Nursing, Neuros Technology

In this planned transition, Veino will join the Board of Directors.

Key Points:

In this planned transition, Veino will join the Board of Directors.
Upon anticipated PMA approval from the FDA, Veino will lead the transition of Neuros from an early-stage company to its commercial execution stage, and beyond.
"The Neuros team is thrilled to have Randy join our Board," says Veino.
Ban joins a highly engaged, talented Board of Directors with a mission of delivering Neuros' innovative technology to physicians and their patients who are seeking relief from chronic post-amputation pain.

Darwinium Raises $18 Million to Accelerate Global Adoption of its Edge-based Digital Security and Fraud Prevention Platform

Retrieved on:

Wednesday, October 18, 2023

SAN FRANCISCO, Oct. 18, 2023 /PRNewswire/ -- Darwinium, a next-generation digital security and fraud prevention platform, today announced it has raised $18 million in Series A financing led by U.S. Venture Partners (USVP), with participation from seed investors: Blackbird, Airtree Ventures and Accomplice. The new funding brings total investment to $26 million and enables Darwinium to scale its edge-based solution across global geographies, where it is quickly gaining traction across multiple vertical industries including fintech, eCommerce, financial services and gaming/gambling.

Key Points:

Online fraud has become more complex and harder to detect, facilitated by AI-tooling that is being exploited by adversaries.
They recommend that "Security and risk management leaders must orchestrate multiple capabilities to create dynamic user journeys while minimizing risk."
Second, it has pioneered a SaaS-based approach to data protection that weaves strong, strategic data security into its unique, edge-based approach.
"Darwinium offers a product that is both simple to deploy and effective at reducing fraud losses and reputational damage associated with the ever-more complex web of digital fraud.

Luminopia, Inc. Announces Closing of Oversubscribed Series A Financing Round

Retrieved on:

Tuesday, June 27, 2023

U.S. Venture Partners (USVP) led the oversubscribed Series A financing round, with participation from new investor Broadfin Advisors, as well as support from existing investors, ShangBay Capital and Vertical Group.

Key Points:

U.S. Venture Partners (USVP) led the oversubscribed Series A financing round, with participation from new investor Broadfin Advisors, as well as support from existing investors, ShangBay Capital and Vertical Group.
With the closing of the round, Casey Tansey, General Partner at USVP, will join Luminopia’s Board of Directors.
Luminopia is also unique among prescription digital therapeutics, as its mechanism of action has a direct treatment effect on patients’ vision.
During the Phase 3 pivotal trial, Luminopia improved vision by 1.8 lines on an eye chart in three months.

Trust Lab Closes $15 Million Investment Led by U.S. Venture Partners

Retrieved on:

Thursday, June 15, 2023

USVP, PALO, ML, General partnership, Foundation Capital, Privacy, Government, Internet, European, U.S. Venture Partners, Entrepreneurship, AI, Social media, Safety, Organization, Cryptocurrency, Trust

PALO ALTO, Calif., June 15, 2023 /PRNewswire/ -- Trust Lab, the company transforming how companies and public entities safeguard Internet users, today announced it has closed a Series A funding round of $15 million, led by U.S. Venture Partners (USVP) and Foundation Capital. The company's technology detects and monitors harmful content and actors using AI-enabled classifiers and rules engines. Using Trust Lab, technology companies and public entities can better track and measure harmful content across the entire Internet. Current customers include the European Commission/European Union, In-Q-Tel, and many leading social media companies, messaging platforms, and marketplaces.

Key Points:

PALO ALTO, Calif., June 15, 2023 /PRNewswire/ -- Trust Lab, the company transforming how companies and public entities safeguard Internet users, today announced it has closed a Series A funding round of $15 million, led by U.S. Venture Partners (USVP) and Foundation Capital.
Using Trust Lab, technology companies and public entities can better track and measure harmful content across the entire Internet.
"Many companies and platforms are throttling their investment in Trust & Safety," said Tom Siegel, Co-Founder and CEO of Trust Lab.
This is one reason why we invest in technology-driven companies focused on security, privacy, and Internet trust and safety."

Surgical Safety Technologies Furthers its Mission of Improving Operating Room Safety and Efficiency With $15 Million in Series A Funding

Retrieved on:

Thursday, May 4, 2023

TORONTO and NEW YORK, May 4, 2023 /PRNewswire/ -- Surgical Safety Technologies (SST), a medical technology company that engineered the OR Black Box® platform for hospitals, has today announced $15 Million in Series A funding. The round was led by U.S. Venture Partners and Santé Ventures, and will be used to accelerate the company's automation initiatives and commercial efforts. SST's platform leverages AI both to inform real-time decision making and provide analytical insight in the areas of safety, compliance and efficiency, which drastically improves patient outcomes and reduces hospital costs.

Key Points:

SST's platform leverages AI both to inform real-time decision making and provide analytical insight in the areas of safety, compliance and efficiency, which drastically improves patient outcomes and reduces hospital costs.
"I am honored to have this support and confidence as we continue our mission of making healthcare safer and more cost-effective," noted Teodor Grantcharov, founder of Surgical Safety Technologies.
Surgical Safety Technologies is developing the operating room of the future, with products that are consistent with Santé's mission of investing in health technologies making meaningful patient impact."
For more information about SST and how the company is improving surgical outcomes for patients across the world, please visit www.surgicalsafety.com .